Tecentriq & Avastin (atezolizumab & bevacizumab)

pCPA File Number: 21289
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0155-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: